Mathematical Prognostic Biomarker Models for Treatment Response and survival in Epithelial Ovarian Cancer

by Jason B. Nikas, Kristin L.M. Boylan, Amy P.N. Skubitz, Walter C. Low
Published 2011-01-01

Mathematical Prognostic Biomarker Models for Treatment Response and Survival in Epithelial Ovarian Cancer

by Jason B. Nikas, Kristin L.M. Boylan, Amy P.N. Skubitz, Walter C. Low
Published 2011-10-01

Inhibition of Ovarian Cancer Cell Spheroid Formation by Synthetic Peptides Derived from Nectin-4

by Kristin L.M. Boylan, Rory D. Manion, Heena Shah, Keith M. Skubitz, Amy P. N. Skubitz
Published 2020-06-01

Motility screen identifies Drosophila IGF-II mRNA-binding protein--zipcode-binding protein acting in oogenesis and synaptogenesis.

by Kristin L M Boylan, Sarah Mische, Mingang Li, Guillermo Marqués, Xavier Morin, William Chia, Thomas S Hays
Published 2008-02-01

A multiplex platform for the identification of ovarian cancer biomarkers

by Kristin L. M. Boylan, Kate Geschwind, Joseph S. Koopmeiners, Melissa A. Geller, Timothy K. Starr, Amy P. N. Skubitz
Published 2017-10-01

Effect of chemotherapy on cancer stem cells and tumor-associated macrophages in a prospective study of preoperative chemotherapy in soft tissue sarcoma

by Keith M. Skubitz, Jon D. Wilson, Edward Y. Cheng, Bruce R. Lindgren, Kristin L. M. Boylan, Amy P. N. Skubitz
Published 2019-04-01

Claudin 4 Is Differentially Expressed between Ovarian Cancer Subtypes and Plays a Role in Spheroid Formation

by Amy P. N. Skubitz, Stefan E. Pambuccian, C. Blake Gilks, Steve E. Kalloger, John D. Andersen, Katherine M. Harrington, Kristin L. M. Boylan, Melissa S. DeRycke, Benjamin Misemer
Published 2011-02-01